Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Research and development spending
3Y CAGR
+133.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
12.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.97M | +18.2% |
| 2024 | $4.21M | +3.0% |
| 2023 | $4.08M | +938.9% |
| 2022 | $392859.00 | - |